Screening and Subcloning of High Producer Transfectomas Using Semisolid Media and Automated Colony Picker
Generation of high-producing clones is a perquisite for achieving recombinant protein yields suitable for biopharmaceutical production. However, in many industrially important cell lines used to produce recombinant proteins such as Chinese hamster ovary, mouse myeloma line (NS0), and hybridomas, only a minority of clones show significantly above-average productivity. Thus, in order to have a reasonable probability of finding rare high-producing clones, a large number of clones need to be screened. Limiting dilution cloning is the most commonly used method, owing to its relative simplicity and low cost. However the use of liquid media in this method makes the selection of monoclonal hybridoma and transfectoma colonies to be labor intensive and time consuming, thus significantly limiting the number of clones that can be feasibly screened. Hence, we describe the use of semisolid media to immobilize clones and a high-throughput, automated colony picker (ClonePix FL) to efficiently isolate monoclonal high-producing clones secreting monoclonal antibodies.
Key wordsHigh-throughput selection Mammalian cells Monoclonal antibodies Recombinant proteins Semisolid media
This work was supported by Inno Biologics and Ministry of Science, Technology and Innovation, Malaysia.
- 9.Lee C, Ly C, Sauerwald T et al (2006) High throughput screening of cell lines expressing monoclonal antibodies. J Ind Microbiol Biotechnol 4:32–35Google Scholar
- 10.Mann CJ (2007) Rapid isolation of antigen-specific clones from hybridoma fusions. Nat Methods 4:i–iiGoogle Scholar
- 11.Dharshanan S, Chong H, Cheah SH et al (2011) Rapid automated selection of mammalian cell line secreting high level of humanized monoclonal antibody using ClonePix FL system and the correlation between exterior median intensity and antibody productivity. Electron J Biotechnol. doi: 10.2225/vol14-issue2-fulltext-7 Google Scholar
- 12.Dharshanan S (2012) Development and production of humanized monoclonal antibodies. Lap Lambert, GermanyGoogle Scholar
- 13.Iznaga-Escobar N, Ramos-Suzarte M, Morales-Morales A et al (2004) 99mTc labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization. Methods Find Exp Clin Pharmacol 26:687–696PubMedCrossRefGoogle Scholar